ADVANCE THE GENE & CELL THERAPY COLLECTIVE Trademark

Trademark Overview


On Friday, July 10, 2020, a trademark application was filed for ADVANCE THE GENE & CELL THERAPY COLLECTIVE with the United States Patent and Trademark Office. The USPTO has given the ADVANCE THE GENE & CELL THERAPY COLLECTIVE trademark a serial number of 90047134. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by Precision Medicine Group, LLC. The ADVANCE THE GENE & CELL THERAPY COLLECTIVE trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry

Business management consulting services to the pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business and management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business services provided to the healthcare industry, namely, the creation, collection, analysis, and reporting of health care data and in...

Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition
advance the gene & cell therapy collective

General Information


Serial Number90047134
Word MarkADVANCE THE GENE & CELL THERAPY COLLECTIVE
Filing DateFriday, July 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements


Goods and ServicesProviding non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry
Pseudo MarkADVANCE THE GENE AND CELL THERAPY COLLECTIVE
Goods and ServicesBusiness management consulting services to the pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business and management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business services provided to the healthcare industry, namely, the creation, collection, analysis, and reporting of health care data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition
Disclaimer with Predetermined Text"GENE & CELL THERAPY COLLECTIVE"
Goods and ServicesScientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 6, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, March 25, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 25, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrecision Medicine Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814

Party NamePrecision Medicine Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814

Trademark Events


Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 27, 2021SOU EXTENSION 1 FILED
Wednesday, October 27, 2021TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 4, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 19, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 19, 2020NON-FINAL ACTION E-MAILED
Thursday, November 19, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Thursday, August 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 14, 2020NEW APPLICATION ENTERED